San Francisco, April 24, 2018: According to a new research report by TMR research, the global market for predictive genetic testing and consumer/wellness genomics is undergoing a phase of remarkable growth. The report, titled “Predictive Genetic Testing and Consumer/Wellness Genomics Market – Global Industry Analysis, Size, Share, Trends, Analysis, Growth, and Forecast 2017 – 2025,” focuses on the key factors that influence the market’s performance. It also takes the existing and historical performance of this market in consideration to determine its future prospects.
As per the research report, the continual expansion in the biotechnology industry and the high investments for the research and developments in the field of genetics are the main factor behind the remarkable growth of the global market for predictive genetic testing and consumer/wellness genomics.
Currently, North America has surfaced as the leading regional market for predictive genetic testing and consumer/wellness genomics and is anticipated to remain so in the near future, thanks to the presence of a strong healthcare infrastructure, increasing prevalence of cardiovascular diseases, and the high adoptability rate of new technologies in this region, states the research report.
Get Sample Copy of this Report @
In conclusion, the research report offers a comprehensive analysis of the competitive landscape prevalent in the global market for predictive genetic testing and consumer/wellness genomics in a bid to understand the hierarchy between the leading players in this market. Color Genomics Inc., 23andMe Inc., Genesis Genetics, BGI, Illumina Inc., Pathway Genomics, Myriad Genetics Inc., and ARUP Laboratories are some of the key companies in this market, reviewed in this research report.